Assad Safary

4.6k total citations
82 papers, 3.5k citations indexed

About

Assad Safary is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Assad Safary has authored 82 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 61 papers in Hepatology and 34 papers in Infectious Diseases. Recurrent topics in Assad Safary's work include Hepatitis B Virus Studies (67 papers), Hepatitis Viruses Studies and Epidemiology (57 papers) and Viral gastroenteritis research and epidemiology (27 papers). Assad Safary is often cited by papers focused on Hepatitis B Virus Studies (67 papers), Hepatitis Viruses Studies and Epidemiology (57 papers) and Viral gastroenteritis research and epidemiology (27 papers). Assad Safary collaborates with scholars based in Belgium, Taiwan and Thailand. Assad Safary's co-authors include Francis André, Pierre Van Damme, S Thoelen, A. Delem, A. Meheus, Geert Leroux‐Roels, Marc Fourneau, Pierre Vandepapelière, Ralf Clemens and G Wiedermann and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Assad Safary

82 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Assad Safary 2.6k 2.4k 1.3k 456 344 82 3.5k
Francis André 1.4k 0.5× 1.7k 0.7× 1.1k 0.9× 349 0.8× 225 0.7× 78 2.8k
Wolfgang Jilg 3.6k 1.4× 3.3k 1.4× 1.9k 1.5× 301 0.7× 691 2.0× 173 5.6k
Saul Krugman 1.5k 0.6× 3.0k 1.2× 1.0k 0.8× 570 1.3× 606 1.8× 103 4.0k
Barbara J. Kuter 1.1k 0.4× 3.0k 1.2× 1.1k 0.9× 709 1.6× 153 0.4× 99 3.9k
William F. Carman 4.1k 1.6× 6.3k 2.7× 1.4k 1.1× 427 0.9× 878 2.6× 121 7.2k
Heather F. Gidding 534 0.2× 1.8k 0.7× 694 0.5× 567 1.2× 157 0.5× 131 2.7k
J E Banatvala 757 0.3× 1.6k 0.7× 826 0.6× 150 0.3× 282 0.8× 88 2.5k
Ian D. Gust 1.8k 0.7× 1.8k 0.8× 1.6k 1.2× 103 0.2× 282 0.8× 161 3.5k
Donald P. Francis 1.1k 0.4× 1.8k 0.8× 972 0.8× 347 0.8× 695 2.0× 52 3.1k
Saleem Kamili 3.1k 1.2× 1.7k 0.7× 1.4k 1.1× 102 0.2× 146 0.4× 118 3.6k

Countries citing papers authored by Assad Safary

Since Specialization
Citations

This map shows the geographic impact of Assad Safary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assad Safary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assad Safary more than expected).

Fields of papers citing papers by Assad Safary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assad Safary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assad Safary. The network helps show where Assad Safary may publish in the future.

Co-authorship network of co-authors of Assad Safary

This figure shows the co-authorship network connecting the top 25 collaborators of Assad Safary. A scholar is included among the top collaborators of Assad Safary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assad Safary. Assad Safary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guptan, R C, Varsha Thakur, Assad Safary, & Shiv Kumar Sarin. (2002). Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix™ in healthy Indian children. Vaccine. 20(16). 2102–2106. 10 indexed citations
2.
Vial, Pablo, et al.. (2001). Efficacy of Hepatitis A Vaccination in Children Aged 12 to 24 Months. Archives of Medical Research. 32(5). 468–472. 9 indexed citations
3.
Dagan, Ron, et al.. (2000). Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. The Pediatric Infectious Disease Journal. 19(11). 1045–1052. 98 indexed citations
4.
Piazza, Marcello, Assad Safary, Angela Vegnente, et al.. (1999). Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine. 17(6). 585–588. 50 indexed citations
5.
Bart, Pierre‐Alexandre, et al.. (1998). Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/ hepatitis B vaccination in 242 adult volunteers. Journal of Viral Hepatitis. 5(3). 205–211. 21 indexed citations
6.
Leroux‐Roels, Geert, Isabelle Desombere, Marie-Anne Petit, et al.. (1997). Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults. Vaccine. 15(16). 1724–1731. 28 indexed citations
7.
Lee, Shou‐Dong, et al.. (1997). Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. Journal of Medical Virology. 52(2). 215–218. 53 indexed citations
8.
Poovorawan, Yong, Suwimol Sanpavat, S Chumdermpadetsuk, & Assad Safary. (1997). Long term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Archives of Disease in Childhood Fetal & Neonatal. 77(1). F47–F51. 54 indexed citations
9.
Findor, Jorge, et al.. (1996). Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later. Journal of Travel Medicine. 3(3). 156–159. 16 indexed citations
10.
Leroux‐Roels, Geert, et al.. (1996). Safety and Immunogenicity of a Combined Hepatitis A and Hepatitis B Vaccine in Young Healthy Adults. Scandinavian Journal of Gastroenterology. 31(10). 1027–1031. 36 indexed citations
11.
Wiedermann, G, et al.. (1994). Thermostability of an inactivated hepatitis A vaccine stored at 37°C for one week. Journal of Medical Virology. 44(4). 442–442. 3 indexed citations
12.
Ambrosch, F, Francis André, A. Delem, et al.. (1992). Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 10. S142–S145. 37 indexed citations
13.
Damme, Pierre Van, et al.. (1992). Heat stability of a recombinant DNA hepatitis B vaccine. Vaccine. 10(6). 366–367. 37 indexed citations
14.
Goubau, Patrick, Assad Safary, A. Delem, et al.. (1992). Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine. Vaccine. 10. S114–S118. 28 indexed citations
15.
Wiedermann, G, et al.. (1992). Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 10. S129–S131. 45 indexed citations
16.
Leentvaar-Kuijpers, A, et al.. (1992). Simultaneous passive and active immunization against hepatitis A. Vaccine. 10. S138–S141. 34 indexed citations
17.
Lee, Chin‐Yun, et al.. (1991). The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. The Pediatric Infectious Disease Journal. 10(4). 299–302. 55 indexed citations
18.
Wiedermann, G, F Ambrosch, Herwig Kollaritsch, et al.. (1990). Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine. 8(6). 581–584. 69 indexed citations
19.
Wiedermann, G, Otto Scheiner, F Ambrosch, et al.. (1988). Lack of Induction of IgE and IgG Antibodies to Yeast in Humans Immunized with Recombinant Hepatitis B Vaccines. International Archives of Allergy and Immunology. 85(1). 130–132. 15 indexed citations
20.
Ambrosch, F, W Frisch-Niggemeyer, Peter G. Kremsner, et al.. (1987). Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.. PubMed. 63 Suppl 2. 129–35. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026